FDA Orders Warning Labels for Sulfite Drugs
- Share via
WASHINGTON — Warning labels on the 1,100 prescription drugs containing sulfites will be required to protect 500,000 Americans who have allergic reactions to the chemicals, the Food and Drug Administration said Friday.
Drug companies will be required to state in warnings to doctors and pharmacists the type of sulfite preservative used in the medication and advise that it might cause allergic reactions, particularly severe asthma attacks, the FDA said.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
More From the Los Angeles Times
Podcasts
In this episode, we discuss the history here, what lessons were learned — and not — and how that can inform what we we do this time around as we attempt to rebuild Altadena and the Pacific Palisades.
This week’s episode covers the sentencing and future legal proceedings for “The Ketamine Queen” — the doctor who pled guilty to supplying Matthew Perry with ketamine.
This week, “A Matter of Degrees,” hosted by Dr. Leah Stokes & Dr. Katharine Wilkinson, discuss how insurance companies are failing to accommodate for the impacts of climate change.
